108 research outputs found

    Interaction of short cracks with the local microstructure

    Get PDF
    AbstractIncreasing the resistance of a material against fatigue crack growth by optimizing the microstructure is one of the major tasks of modern materials science. Thereby grain and phase boundaries are microstructural elements which can decelerate the propagation rate especially of short cracks. However, in different materials cracks and grain boundaries interact differently. For instance in some steels the blocking effect was only found for large angle grain boundaries while small angle boundaries showed nearly no effect. On the other hand in nickel based superalloys a retardation of cracks was found even for small angle boundaries when the crack was propagating in stage I. Even in front of the same grain boundary, the blocking effect varies for different cracks. To investigate this behaviour systematically focused ion beam (FIB) initiated cracks were used. By this method of artificial crack initiation the crack parameters like crack length and distance to the obstacle can be varied separately. Additionally special grain boundaries can be selected after a microstructural characterisation by electron backscatter diffraction (EBSD). Finally FIB tomography helps to understand the process how a crack overcomes a grain boundary

    Hard multilayered thin films of metal–intermetallic Ni/Ni3Al

    Get PDF
    Metal-intermetallic Ni/Ni3Al multilayered thin films were synthesized by the magnetron sputtering technique. The synthesized films possessed high hardness that could be compared with intermetallic Ni3Al films. The constituent layers of Ni and Ni3Al were fully adherent to one another at the multilayered boundaries. The fracture surface of the multilayered films on bending showed the characteristics of local ductile fracture. This novel type of multilayered thin films is expected to be used as hard coatings and miniaturized parts of apparatus in micro-electromechanical systems.published_or_final_versio

    Fractography, elastic modulus and oxidation resistance of novel metal-intermetallic Ni/Ni 3Al multilayer films

    Get PDF
    Novel metal–intermetallic Ni/Ni3Al multilayer films are synthesized by a magnetron sputtering technique. The fractography, elastic modulus, and the oxidation resistance of the multilayer films are studied by a series of experimental tests. The scanning electron microscopy fractography of the films shows that both Ni and Ni3Al layers fracture with the appearance of ductile metal failure. No metal–intermetallic delamination appears in the multilayered films. Fluted dimpling in each Ni and Ni3Al layer is evident and continuous, layer through layer, illustrating very good adherence among the constituent layers. Such adherence makes the toughness of the Ni layers capable of transferring into the Ni3Al layers. Young’s modulus of the Ni/Ni3Al film is found to be 226 and 253 ± 10 GPa by nanoindentation and laser acoustic techniques, respectively. The continuity of elastic modulus between the two phases is revealed by nanoindentation test. The modulus continuity indicates an excellent integration of the constituent layers with similar crystal structure and close lattice constants. This integration makes the multilayers unsurpassed in comprehensive mechanical properties. Sheet resistance measurements show a good protective ability of the Ni/Ni3Al multilayers during high temperature oxidation. X-ray photoelectron spectroscopy spectra suggest that crystallized Al2O3 /Ni scales formed during the deposition and subsequent annealing processes are apparently responsible for the stability of these films under oxidative conditions. The appearance of the crystallized Al2O3 /Ni thin scales on the top of Ni3Al layers provides the Ni/Ni3Al multilayers good thermal oxidation resistance without lowering the fracture toughness.published_or_final_versio

    Mid-infrared interferometry of massive young stellar objects

    Full text link
    The very inner structure of massive young stellar objects (YSOs) is difficult to trace. With conventional observational methods we identify structures still several hundreds of AU in size. However, the (proto-)stellar growth takes place at the innermost regions (<100 AU) where the actual mass transfer onto the forming high-mass star occurs. We present results from our programme toward massive YSOs at the VLTI, utilising the two-element interferometer MIDI. To date, we observed 10 well-known massive YSOs down to scales of 20 mas (typically corresponding to 20 - 40 AU for our targets) in the 8-13 micron region. We clearly resolve these objects which results in low visibilities and sizes in the order of 30-50 mas. For two objects, we show results of our modelling. We demonstrate that the MIDI data can reveal decisive structure information for massive YSOs. They are often pivotal in order to resolve ambiguities still immanent in model parameters derived from sole SED fitting.Comment: 6 pages, 5 figures, necessary style files iopams.sty, jpconf11.clo, and jpconf.cls included; contribution for the conference "The Universe under the Microscope" (AHAR 2008), held in Bad Honnef (Germany) in April 2008, to be published in Journal of Physics: Conference Series by Institute of Physics Publishing, R. Schoedel, A. Eckart, S. Pfalzner, and E. Ros (eds.

    Probing the envelopes of massive young stellar objects with diffraction limited mid-infrared imaging

    Full text link
    Massive stars form whilst they are still embedded in dense envelopes. As a result, the roles of rotation, mass loss and accretion in massive star formation are not well understood. This study evaluates the source of the Q-band, lambda=19.5 microns, emission of massive young stellar objects (MYSOs). This allows us to determine the relative importance of rotation and outflow activity in shaping the circumstellar environments of MYSOs on 1000 AU scales. We obtained diffraction limited mid-infrared images of a sample of 20 MYSOs using the VLT/VISIR and Subaru/COMICS instruments. For these 8 m class telescopes and the sample selected, the diffraction limit, ~0.6", corresponds to approximately 1000 AU. We compare the images and the spectral energy distributions (SEDs) observed to a 2D, axis-symmetric dust radiative transfer model that reproduces VLTI/MIDI observations of the MYSO W33A. We vary the inclination, mass infall rate, and outflow opening angle to simultaneously recreate the behaviour of the sample of MYSOs in the spatial and spectral domains. The mid-IR emission of 70 percent of the MYSOs is spatially resolved. In the majority of cases, the spatial extent of their emission and their SEDs can be reproduced by the W33A model featuring an in-falling, rotating dusty envelope with outflow cavities. There is independent evidence that most of the sources which are not fit by the model are associated with ultracompact HII regions and are thus more evolved. We find that, in general, the diverse 20 micron morphology of MYSOs can be attributed to warm dust in the walls of outflow cavities seen at different inclinations. This implies that the warm dust in the outflow cavity walls dominates the Q-band emission of MYSOs. In turn, this emphasises that outflows are an ubiquitous feature of massive star formation.Comment: Accepted for publication in A&A. The images in this version have been compressed. A high resolution version is available on reques

    Carotid plaque surface echogenicity predicts cerebrovascular events: An Echographic Multicentric Swiss Study.

    Get PDF
    BACKGROUND AND PURPOSE To determine the prognostic value for ischemic stroke or transitory ischemic attack (TIA) of plaque surface echogenicity alone or combined to degree of stenosis in a Swiss multicenter cohort METHODS: Patients with ≥60% asymptomatic or ≥50% symptomatic carotid stenosis were included. Grey-scale based colour mapping was obtained of the whole plaque and of its surface defined as the regions between the lumen and respectively 0-0.5, 0-1, 0-1.5, and 0-2 mm of the outer border of the plaque. Red, yellow and green colour represented low, intermediate or high echogenicity. Proportion of red color on surface (PRCS) reflecting low echogenictiy was considered alone or combined to degree of stenosis (Risk index, RI). RESULTS We included 205 asymptomatic and 54 symptomatic patients. During follow-up (median/mean 24/27.7 months) 27 patients experienced stroke or TIA. In the asymptomatic group, RI ≥0.25 and PRCS ≥79% predicted stroke or TIA with a hazard ratio (HR) of respectively 8.7 p = 0.0001 and 10.2 p < 0.0001. In the symptomatic group RI ≥0.25 and PRCS ≥81% predicted stroke or TIA occurrence with a HR of respectively 6.1 p = 0.006 and 8.9 p = 0.001. The best surface parameter was located at 0-0.5mm. Among variables including age, sex, degree of stenosis, stenosis progression, RI, PRCS, grey median scale values and clinical baseline status, only PRCS independently prognosticated stroke (p = 0.005). CONCLUSION In this pilot study including patients with at least moderate degree of carotid stenosis, PRCS (0-0.5mm) alone or combined to degree of stenosis strongly predicted occurrence of subsequent cerebrovascular events

    Central Retinal Artery Occlusion: Current Practice, Awareness and Prehospital Delays in Switzerland

    Full text link
    BACKGROUND AND PURPOSE: Central retinal artery occlusion (CRAO) often leads to permanent monocular blindness. Hence, early recognition and rapid re-perfusion is of paramount importance. This study aims to describe prehospital pathways in CRAO compared to stroke and study the knowledge about CRAO. METHODS: (1) Description of baseline characteristics, prehospital pathways/delays, and acute treatment (thrombolysis/thrombectomy vs. standard of care) of patients with CRAO and ischemic stroke registered in the Swiss Stroke Registry. (2) Online survey about CRAO knowledge amongst population, general practitioners (GPs) and ophthalmologists in Eastern Switzerland. RESULTS: Three hundred and ninety seven CRAO and 32,816 ischemic stroke cases were registered from 2014 until 2019 in 20 Stroke Centers/Units in Switzerland. In CRAO, 25.6% arrived at the hospital within 4 h of symptom onset and had a lower rate of emergency referrals. Hence, the symptom-to-door time was significantly longer in CRAO compared to stroke (852 min. vs. 300 min). The thrombolysis/thrombectomy rate was 13.2% in CRAO and 30.9% in stroke. 28.6% of the surveyed population recognized CRAO-symptoms, 55.4% of which would present directly to the emergency department in contrast to 90.0% with stroke symptoms. Almost 100% of the ophthalmologist and general practitioners recognized CRAO as a medical emergency and 1/3 of them considered IV thrombolysis a potentially beneficial therapy. CONCLUSIONS: CRAO awareness of the general population and physician awareness about the treatment options as well as the non-standardized prehospital organization, seems to be the main reason for the prehospital delays and impedes treating CRAO patients. Educational efforts should be undertaken to improve awareness about CRAO

    Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.

    Get PDF
    BACKGROUND Evidence-based hemostatic treatment for intracerebral hemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOACs) is lacking. Tranexamic acid (TXA) is an antifibrinolytic drug potentially limiting hematoma expansion. We aimed to assess the efficacy and safety of TXA in NOAC-ICH. METHODS We performed a double-blind, randomized, placebo-controlled trial at 6 Swiss stroke centers. Patients with NOAC-ICH within 12 hours of symptom onset and 48 hours of last NOAC intake were randomized (1:1) to receive either intravenous TXA (1 g over 10 minutes followed by 1 g over 8 hours) or matching placebo in addition to standard medical care via a centralized Web-based procedure with minimization on key prognostic factors. All participants and investigators were masked to treatment allocation. Primary outcome was hematoma expansion, defined as ≥33% relative or ≥6 mL absolute volume increase at 24 hours and analyzed using logistic regression adjusted for baseline hematoma volume on an intention-to-treat basis. RESULTS Between December 12, 2016, and September 30, 2021, we randomized 63 patients (median age, 82 years [interquartile range, 76-86]; 40% women; median hematoma volume, 11.5 [4.8-27.4] mL) of the 109 intended sample size before premature trial discontinuation due to exhausted funding. The primary outcome did not differ between TXA (n=32) and placebo (n=31) arms (12 [38%] versus 14 [45%]; adjusted odds ratio, 0.63 [95% CI, 0.22-1.82]; P=0.40). There was a signal for interaction with onset-to-treatment time (Pinteraction=0.024), favoring TXA when administered within 6 hours of symptom onset. Between the TXA and placebo arms, the proportion of participants who died (15 [47%] versus 13 [42%]; adjusted odds ratio, 1.07 [0.37-3.04]; P=0.91) or had major thromboembolic complications within 90 days (4 [13%] versus 2 [6%]; odds ratio, 1.86 [0.37-9.50]; P=0.45) did not differ. All thromboembolic events occurred at least 2 weeks after study treatment, exclusively in participants not restarted on oral anticoagulation. CONCLUSIONS In a smaller-than-intended NOAC-ICH patient sample, we found no evidence that TXA prevents hematoma expansion, but there were no major safety concerns. Larger trials on hemostatic treatments targeting an early treatment window are needed for NOAC-ICH. REGISTRATION URL: https://clinicaltrials.gov; Unique identifier: NCT02866838

    Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial

    Get PDF
    BACKGROUND: Evidence-based hemostatic treatment for intracerebral hemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOACs) is lacking. Tranexamic acid (TXA) is an antifibrinolytic drug potentially limiting hematoma expansion. We aimed to assess the efficacy and safety of TXA in NOAC-ICH. METHODS: We performed a double-blind, randomized, placebo-controlled trial at 6 Swiss stroke centers. Patients with NOAC-ICH within 12 hours of symptom onset and 48 hours of last NOAC intake were randomized (1:1) to receive either intravenous TXA (1 g over 10 minutes followed by 1 g over 8 hours) or matching placebo in addition to standard medical care via a centralized Web-based procedure with minimization on key prognostic factors. All participants and investigators were masked to treatment allocation. Primary outcome was hematoma expansion, defined as ≥33% relative or ≥6 mL absolute volume increase at 24 hours and analyzed using logistic regression adjusted for baseline hematoma volume on an intention-to-treat basis. RESULTS: Between December 12, 2016, and September 30, 2021, we randomized 63 patients (median age, 82 years [interquartile range, 76-86]; 40% women; median hematoma volume, 11.5 [4.8-27.4] mL) of the 109 intended sample size before premature trial discontinuation due to exhausted funding. The primary outcome did not differ between TXA (n=32) and placebo (n=31) arms (12 [38%] versus 14 [45%]; adjusted odds ratio, 0.63 [95% CI, 0.22-1.82]; P=0.40). There was a signal for interaction with onset-to-treatment time (Pinteraction_{interaction}=0.024), favoring TXA when administered within 6 hours of symptom onset. Between the TXA and placebo arms, the proportion of participants who died (15 [47%] versus 13 [42%]; adjusted odds ratio, 1.07 [0.37-3.04]; P=0.91) or had major thromboembolic complications within 90 days (4 [13%] versus 2 [6%]; odds ratio, 1.86 [0.37-9.50]; P=0.45) did not differ. All thromboembolic events occurred at least 2 weeks after study treatment, exclusively in participants not restarted on oral anticoagulation. CONCLUSIONS: In a smaller-than-intended NOAC-ICH patient sample, we found no evidence that TXA prevents hematoma expansion, but there were no major safety concerns. Larger trials on hemostatic treatments targeting an early treatment window are needed for NOAC-ICH

    Circumstellar disks and planets. Science cases for next-generation optical/infrared long-baseline interferometers

    Full text link
    We present a review of the interplay between the evolution of circumstellar disks and the formation of planets, both from the perspective of theoretical models and dedicated observations. Based on this, we identify and discuss fundamental questions concerning the formation and evolution of circumstellar disks and planets which can be addressed in the near future with optical and infrared long-baseline interferometers. Furthermore, the importance of complementary observations with long-baseline (sub)millimeter interferometers and high-sensitivity infrared observatories is outlined.Comment: 83 pages; Accepted for publication in "Astronomy and Astrophysics Review"; The final publication is available at http://www.springerlink.co
    • …
    corecore